Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

OpGen Inc.

Mar 2011
A commercial phase genomics and DNA analysis company, OpGen Inc. of Gaithersburg, Md., has announced that Wellcome Trust Sanger Institute of Hinxton, UK, has purchased an Argus optical mapping system to reduce the time and cost of whole genome sequence assembly. The institute’s Mapping and Archive Sequencing Div. will use the system for optical mapping of bacteria and parasites. By using an optical map as the whole genome scaffold, researchers now can identify gaps in the sequence and can target specific areas of the genome for additional sequencing.

ArgusBiophotonicsBusinessDNA analhsisgenome sequencingOpGenoptical mapping systemopticsphase genomicsRapidScanWellcome Trust Sanger Institute

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.